Markets:

Overview

News

Currencies

International

Treasuries

Immatics N.V. - Ordinary Shares (NQ:IMTX)

7.706 -0.024 (-0.31%)

Delayed Quote Updated: 9:31 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immatics N.V. - Ordinary Shares

< Previous 1 2 Next >

Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures

October 20, 2025

Adaptimmune Therapeutics plc (NASDAQ: ADAP) has sent shockwaves through the biotechnology sector with its announcement on October 20, 2025, of a voluntary delisting of its American Depositary Shares...

Via MarketMinute

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

Why Immatics Shares Are Rising Today ↗

July 24, 2023

Immatics N.V. (NASDAQ: IMTX) shares are trading higher after the company announced

Via Benzinga

Recap: Immatics Q1 Earnings ↗

May 16, 2023

Via Benzinga

Why Immatics Stock Is Soaring Today ↗

May 02, 2023

Investors liked what they heard in Immatics' interim results for experimental immunotherapy IMA203.

Via The Motley Fool

Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 03, 2025

Via Benzinga

Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday? ↗

October 10, 2024

Immatics announced updated Phase 1b data for its IMA203 therapy in metastatic melanoma. A deep tumor reduction response was observed in about half of the patients, with positive survival benefits...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 10, 2024

Via Benzinga

Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗

October 01, 2024

Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.

Via Talk Markets

IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024 ↗

August 13, 2024

IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 24, 2024

Via Benzinga

IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023 ↗

March 21, 2024

IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 21, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Top 5 Health Care Stocks That May Crash This Month ↗

June 22, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 02, 2023

Via Benzinga

What's Going On With Immatics Shares Today ↗

May 02, 2023

Immatics N.V. (NASDAQ: IMTX) shares are shooting higher today after it revealed an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine...

Via Benzinga

US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns ↗

May 02, 2023

U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 02, 2023

Via Benzinga

Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration ↗

May 01, 2023

Bristol-Myers Squibb Co (NYSE: BMY) announced

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 ↗

March 31, 2023

Via Benzinga

First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

March 21, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday ↗

October 10, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session.

Via Benzinga

Why Is Nutex Health (NUTX) Stock on the Move Today? ↗

October 10, 2022

Nutex Health (NUTX) stock is moving on Monday after the healthcare management company released a corporate update to investors.

Via InvestorPlace

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.